A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia

Launched by TAKEDA · Apr 25, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the safety of the QDENGA vaccine, which is used to protect against dengue fever, a serious illness spread by mosquitoes. Researchers want to find out what kinds of health issues people might experience after getting the vaccine and how many vaccinated individuals may need to be hospitalized due to severe dengue fever. It’s important to note that if you join this study, you won’t be receiving the vaccine; instead, the study will collect information from those who have already been vaccinated and agree to participate.

To be eligible for this study, you must have received at least one dose of the QDENGA vaccine in Malaysia during the study period and have a working phone number. There are no specific exclusions, which means if you meet these criteria, you can participate. If you take part, you can expect to share your experiences and any health issues you may have noticed after your vaccination, helping researchers better understand the vaccine's effects. Your input will play a vital role in improving vaccination efforts and ensuring the safety of those receiving the QDENGA vaccine.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Participants who have received at least one dose of QDENGA vaccine in Malaysia during the study period.
• • 2. Participants or their legally authorized representative (LARs) with a functioning phone number.
• Exclusion Criteria:
• • No exclusion criteria will be applied for this study.